Welcome: Guest | Site Use Options | Register | Login |

Talee Bio Inc

Talee Bio Inc

Profile last edited on: 1/25/2019
3001 Market Street Suite 140
Philadelphia, PA 19104
  (215) 239-6271
  info@taleebio.com
  www.taleebio.com/
Business Identifier: Gene therapy company developing next generation treatment and cures for cystic fibrosis
Public Profile:
Talee Bio is developing a gene therapy for cystic fibrosis (CF), the first curative treatment for this disease. Talee has developed a novel transgene and a number of innovations in a well-characterized delivery vector that collectively will overcome challenges that have previously limited the clinical viability of gene therapy for CF. Rspresenting a collaboration among drug development professionals with more than 60 years of combined experience, and academic founders of the company, from the University of Iowa, who have been investigating CF pathogenesis and treatment, including gene therapy strategies, for more than 25 years.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news



WikiProfile

Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com